Taylor Wessing advised Healx on its funding round. Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases based in Cambridge UK, has raised $47 million...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here